Sign in to view content

Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study

Ananda Kalevar, MD, FRCS(C), DABO

Video
Published 2020

Related

Long-Term Efficacy and Safety of the Port Delivery System With Ranibizumab in Patients With nAMD: Results of the Portal 5-year Subgroup Analysis
David J Massop, MD
Annual Meeting Talks
2023
Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
Study of Comparative Treatments for REtinal Vein Occlusion 2 (SCORE2): Primary Results
Ingrid U. Scott, MD, MPH
Updates from the Field
2017

Category: AMD-Neovascular

See more